Vigilare Wealth Management Ocular Therapeutix, Inc Transaction History

Vigilare Wealth Management

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 06, 2022	SELL	$4.83 - $7.35 $103,700 - $157,804	-21,470 Closed	0 $0
Q4 2021 Jan 07, 2022	SELL	$6.16 - $12.07 $122,892 - $240,796	-19,950 Reduced 48.17%	21,470 $150,000
Q3 2021 Oct 19, 2021	BUY	$9.7 - $14.34 $95,351 - $140,962	9,830 Added 31.12%	41,420 $414,000
Q2 2021 Jul 16, 2021	BUY	$13.43 - $19.16 $113,214 - $161,518	8,430 Added 36.4%	31,590 $448,000
Q1 2021 Apr 29, 2021	BUY	$15.82 - $22.11 $152,425 - $213,029	9,635 Added 71.24%	23,160 $380,000
Q4 2020 Jan 14, 2021	SELL	$7.91 - $22.95 $36,979 - $107,291	-4,675 Reduced 25.69%	13,525 $280,000
Q3 2020 Oct 15, 2020	BUY	$7.36 - $9.87 $6,624 - $8,883	900 Added 5.2%	18,200 $139,000
Q2 2020 Jul 20, 2020	BUY	$4.67 - $8.95 $80,791 - $154,835	17,300 New	17,300 $144,000

172

138M

150K

225K

Ticker OCUL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,966,896
Market Cap $705M
Description
Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...

Get notified when there are updates to the investment portfolio of Vigilare Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Vigilare Wealth Management with notifications on news.